Morgan Stanley’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
91,283
+3,389
| +4% | +$10.8K | ﹤0.01% | 5697 |
|
|
2025
Q1 | $356K | Sell |
87,894
-6,089
| -6% | -$24.7K | ﹤0.01% | 5487 |
|
|
2024
Q4 | $996K | Sell |
93,983
-5,984
| -6% | -$63.4K | ﹤0.01% | 5093 |
|
|
2024
Q3 | $2.47M | Buy |
99,967
+6,327
| +7% | +$156K | ﹤0.01% | 4497 |
|
|
2024
Q2 | $2.64M | Sell |
93,640
-538
| -0.6% | -$15.2K | ﹤0.01% | 4373 |
|
|
2024
Q1 | $3.83M | Sell |
94,178
-118,635
| -56% | -$4.83M | ﹤0.01% | 4125 |
|
|
2023
Q4 | $3.51M | Buy |
212,813
+162,516
| +323% | +$2.68M | ﹤0.01% | 4601 |
|
|
2023
Q3 | $1.91M | Sell |
50,297
-2,125
| -4% | -$80.5K | ﹤0.01% | 4419 |
|
|
2023
Q2 | $2.88M | Buy |
52,422
+1,043
| +2% | +$57.4K | ﹤0.01% | 4180 |
|
|
2023
Q1 | $2.21M | Buy |
51,379
+2,181
| +4% | +$93.8K | ﹤0.01% | 4398 |
|
|
2022
Q4 | $1.93M | Buy |
49,198
+510
| +1% | +$20K | ﹤0.01% | 4494 |
|
|
2022
Q3 | $2.59M | Buy |
48,688
+28,306
| +139% | +$1.5M | ﹤0.01% | 4254 |
|
|
2022
Q2 | $1.34M | Sell |
20,382
-953
| -4% | -$62.5K | ﹤0.01% | 4823 |
|
|
2022
Q1 | $1.57M | Sell |
21,335
-3,080
| -13% | -$226K | ﹤0.01% | 4689 |
|
|
2021
Q4 | $1.73M | Buy |
24,415
+735
| +3% | +$52K | ﹤0.01% | 4683 |
|
|
2021
Q3 | $5.94M | Sell |
23,680
-1,751
| -7% | -$439K | ﹤0.01% | 3491 |
|
|
2021
Q2 | $6.84M | Buy |
25,431
+25,368
| +40,267% | +$6.82M | ﹤0.01% | 3435 |
|
|
2021
Q1 | $18K | Sell |
63
-844
| -93% | -$241K | ﹤0.01% | 6752 |
|
|
2020
Q4 | $257K | Buy |
907
+715
| +372% | +$203K | ﹤0.01% | 5462 |
|
|
2020
Q3 | $59K | Buy |
+192
| New | +$59K | ﹤0.01% | 5663 |
|